skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine

Abstract

Mesenchymal stem cells (MSCs) are capable of self-renewal and differentiation into multiple cell lineages. Presently, bone marrow is considered as a prime source of MSCs; however, there are some drawbacks and limitations in use of these MSCs for cell therapy. In this study, we demonstrate that human gingival tissue-derived MSCs have several advantages over bone marrow-derived MSCs. Gingival MSCs are easy to isolate, homogenous and proliferate faster than bone marrow MSCs without any growth factor. Importantly, gingival MSCs display stable morphology and do not loose MSC characteristic at higher passages. In addition, gingival MSCs maintain normal karyotype and telomerase activity in long-term cultures, and are not tumorigenic. Thus, we reveal that human gingiva is a better source of MSCs than bone marrow, and large number of functionally competent clinical grade MSCs can be generated in short duration for cell therapy in regenerative medicine and tissue engineering.

Authors:
; ; ; ;  [1];  [2];  [1]
  1. National Center for Cell Science, University of Pune Campus, Pune 411 007 (India)
  2. Department of Periodontics and Oral Implantology, Dr. D.Y. Patil Dental College and Hospital, Pune (India)
Publication Date:
OSTI Identifier:
22202401
Resource Type:
Journal Article
Journal Name:
Biochemical and Biophysical Research Communications
Additional Journal Information:
Journal Volume: 393; Journal Issue: 3; Other Information: Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0006-291X
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; BONE MARROW; COLONY FORMING UNITS; DRUGS; EDTA; FIBROBLASTS; GLUCOSE; GROWTH FACTORS; KARYOTYPE; MORPHOLOGY; PHOSPHATES; RECEPTORS; STEM CELLS; THERAPY; TRYPSIN

Citation Formats

Tomar, Geetanjali B., Srivastava, Rupesh K., Gupta, Navita, Barhanpurkar, Amruta P., Pote, Satish T., Jhaveri, Hiral M., Mishra, Gyan C., and Wani, Mohan R., E-mail: mohanwani@nccs.res.in. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. United States: N. p., 2010. Web. doi:10.1016/J.BBRC.2010.01.126.
Tomar, Geetanjali B., Srivastava, Rupesh K., Gupta, Navita, Barhanpurkar, Amruta P., Pote, Satish T., Jhaveri, Hiral M., Mishra, Gyan C., & Wani, Mohan R., E-mail: mohanwani@nccs.res.in. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. United States. https://doi.org/10.1016/J.BBRC.2010.01.126
Tomar, Geetanjali B., Srivastava, Rupesh K., Gupta, Navita, Barhanpurkar, Amruta P., Pote, Satish T., Jhaveri, Hiral M., Mishra, Gyan C., and Wani, Mohan R., E-mail: mohanwani@nccs.res.in. 2010. "Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine". United States. https://doi.org/10.1016/J.BBRC.2010.01.126.
@article{osti_22202401,
title = {Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine},
author = {Tomar, Geetanjali B. and Srivastava, Rupesh K. and Gupta, Navita and Barhanpurkar, Amruta P. and Pote, Satish T. and Jhaveri, Hiral M. and Mishra, Gyan C. and Wani, Mohan R., E-mail: mohanwani@nccs.res.in},
abstractNote = {Mesenchymal stem cells (MSCs) are capable of self-renewal and differentiation into multiple cell lineages. Presently, bone marrow is considered as a prime source of MSCs; however, there are some drawbacks and limitations in use of these MSCs for cell therapy. In this study, we demonstrate that human gingival tissue-derived MSCs have several advantages over bone marrow-derived MSCs. Gingival MSCs are easy to isolate, homogenous and proliferate faster than bone marrow MSCs without any growth factor. Importantly, gingival MSCs display stable morphology and do not loose MSC characteristic at higher passages. In addition, gingival MSCs maintain normal karyotype and telomerase activity in long-term cultures, and are not tumorigenic. Thus, we reveal that human gingiva is a better source of MSCs than bone marrow, and large number of functionally competent clinical grade MSCs can be generated in short duration for cell therapy in regenerative medicine and tissue engineering.},
doi = {10.1016/J.BBRC.2010.01.126},
url = {https://www.osti.gov/biblio/22202401}, journal = {Biochemical and Biophysical Research Communications},
issn = {0006-291X},
number = 3,
volume = 393,
place = {United States},
year = {Fri Mar 12 00:00:00 EST 2010},
month = {Fri Mar 12 00:00:00 EST 2010}
}